BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 25347443)

  • 1. Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent.
    Holmes SE; Bachran C; Fuchs H; Weng A; Melzig MF; Flavell SU; Flavell DJ
    Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):42-55. PubMed ID: 25347443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane cholesterol is essential for triterpenoid saponin augmentation of a saporin-based immunotoxin directed against CD19 on human lymphoma cells.
    Smith WS; Baker EJ; Holmes SE; Koster G; Hunt AN; Johnston DA; Flavell SU; Flavell DJ
    Biochim Biophys Acta Biomembr; 2017 May; 1859(5):993-1007. PubMed ID: 28235471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.
    Smith WS; Johnston DA; Holmes SE; Wensley HJ; Flavell SU; Flavell DJ
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
    Flavell DJ; Warnes SL; Bryson CJ; Field SA; Noss AL; Packham G; Flavell SU
    Br J Haematol; 2006 Jul; 134(2):157-70. PubMed ID: 16771848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Cholesterol on Triterpenoid Saponin-Induced Endolysosomal Escape of a Saporin-Based Immunotoxin.
    Smith WS; Johnston DA; Wensley HJ; Holmes SE; Flavell SU; Flavell DJ
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
    Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin.
    Gilabert-Oriol R; Thakur M; Haussmann K; Niesler N; Bhargava C; Görick C; Fuchs H; Weng A
    Planta Med; 2016 Dec; 82(18):1525-1531. PubMed ID: 27392242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure.
    Bachran C; Sutherland M; Heisler I; Hebestreit P; Melzig MF; Fuchs H
    Exp Biol Med (Maywood); 2006 Apr; 231(4):412-20. PubMed ID: 16565437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of toxicity of saporin-based toxins by Gypsophila saponins--kinetic of the saponin.
    Weng A; Görick C; Melzig MF
    Exp Biol Med (Maywood); 2009 Aug; 234(8):961-6. PubMed ID: 19491365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for isolation of Gypsophila saponins for the combined application of targeted toxins and saponins in tumor therapy.
    Weng A; Bachran D; Görick C; Bachran C; Fuchs H; Melzig MF
    Planta Med; 2009 Oct; 75(13):1421-2. PubMed ID: 19452437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATG-saporin-S6 immunotoxin: a new potent and selective drug to eliminate activated lymphocytes and lymphoma cells.
    Polito L; Bortolotti M; Farini V; Pedrazzi M; Tazzari PL; Bolognesi A
    Br J Haematol; 2009 Dec; 147(5):710-8. PubMed ID: 19764990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor growth by targeted toxins in mice is dramatically improved by saponinum album in a synergistic way.
    Bachran C; Dürkop H; Sutherland M; Bachran D; Müller C; Weng A; Melzig MF; Fuchs H
    J Immunother; 2009 Sep; 32(7):713-25. PubMed ID: 19561537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
    Flavell DJ; Warnes S; Noss A; Flavell SU
    Cancer Res; 1998 Dec; 58(24):5787-94. PubMed ID: 9865737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified trastuzumab and cetuximab mediate efficient toxin delivery while retaining antibody-dependent cell-mediated cytotoxicity in target cells.
    Gilabert-Oriol R; Thakur M; von Mallinckrodt B; Hug T; Wiesner B; Eichhorst J; Melzig MF; Fuchs H; Weng A
    Mol Pharm; 2013 Nov; 10(11):4347-57. PubMed ID: 24050452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.
    Yip WL; Weyergang A; Berg K; Tønnesen HH; Selbo PK
    Mol Pharm; 2007; 4(2):241-51. PubMed ID: 17263556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of saporin cytotoxicity by Gypsophila saponins--more than stimulation of endocytosis.
    Weng A; Bachran C; Fuchs H; Krause E; Stephanowitz H; Melzig MF
    Chem Biol Interact; 2009 Oct; 181(3):424-9. PubMed ID: 19615984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Small Molecule Pharmacological Agents on the Triterpenoid Saponin Induced Endolysosomal Escape of Saporin and a Saporin-Based Immunotoxin in Target Human Lymphoma Cells.
    Wensley HJ; Smith WS; Holmes SE; Flavell SU; Flavell DJ
    Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33804080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid-chromatographic profiling of Saponinum album (Merck).
    Weng A; Thakur M; Schindler A; Fuchs H; Melzig MF
    Pharmazie; 2011 Oct; 66(10):744-6. PubMed ID: 22026154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours.
    Flavell DJ; Flavell SU; Boehm DA; Emery L; Noss A; Ling NR; Richardson PR; Hardie D; Wright DH
    Br J Cancer; 1995 Dec; 72(6):1373-9. PubMed ID: 8519647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.